Lexeo Therapeutics, Inc. (LXEO)

CIK 1907108 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lexeo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 19, 202640001995218-26-000015
Aug 19, 202640002083206-26-000007
Aug 19, 202640002024096-26-000013
Aug 18, 20261440001959173-26-006154
Aug 18, 20261440001959173-26-006152
Aug 18, 20261440001959173-26-006153
Aug 14, 2026SCHEDULE 13G0000947871-26-000801
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097207
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003428
Aug 13, 2026SCHEDULE 13G/A0001011438-26-000515
Aug 12, 202610-Q0001193125-26-345724
Aug 12, 20268-K0001193125-26-345722
Aug 7, 2026SCHEDULE 13G0000093751-26-000489
Jul 1, 202640002083206-26-000005
Jul 1, 202640002109299-26-000007
Jul 1, 20261440001959173-26-005033
Jul 1, 202640002024096-26-000011
Jul 1, 202640001995218-26-000013
Jul 1, 20261440001959173-26-005032
Jul 1, 20261440001959173-26-005031
Jul 1, 20261440001959173-26-005036
Jun 29, 202640001250086-26-000002
Jun 29, 202640001816206-26-000005
Jun 29, 202640001193675-26-000002
Jun 29, 202640001849458-26-000001